Skip to main content
Membership NewsMembership News Archive

UK NSC endorses digital pathology for certain screening programmes

By January 17, 2024No Comments

Based on evidence presented and consultation responses, the UK National Screening Committee (UK NSC) has endorsed the use of digital pathology for histopathology as a permissive modification in the bowel cancer, breast and cervical screening programmes.

The committee was satisfied that digital pathology represents a safe optional alternative to light microscopy for commissioners and providers of diagnostic pathways in the 3 cancer screening programmes.

See minutes of the UK NSC November 2023 meeting.